For research use only. Not for human consumption.
Cagrilintide is a novel long-acting synthetic lipidated peptide analog of human amylin. It acts as a non-selective agonist at amylin receptors (AMYR1, AMYR2, AMYR3) and calcitonin receptors (CTR), designed specifically for prolonged metabolic activity and weight management studies.
$100.00
Cagrilintide is a novel long-acting synthetic lipidated peptide analog of human amylin. It acts as a non-selective agonist at amylin receptors (AMYR1, AMYR2, AMYR3) and calcitonin receptors (CTR), designed specifically for prolonged metabolic activity and weight management studies.
Central Satiety & Appetite Regulation: Studied for binding to amylin and calcitonin receptors in the area postrema and hindbrain to promote sustained feeling of fullness and suppress food intake.
Gastric Motility Delay: Evaluated for slowing the rate of gastric emptying, thereby blunting postprandial glucose spikes and modulating nutrient absorption speeds.
Synergistic Metabolic Combination: Researched extensively alongside GLP-1 and GIP/GLP-1 receptor agonists (such as Semaglutide or Tirzepatide) to investigate multi-pathway weight reduction and metabolic control.
To provide a long-acting amylin receptor agonist for investigating non-incretin weight regulation pathways, hindbrain satiety signaling, delayed gastric transit, and combination metabolic therapies in laboratory research.
| Property | Details |
| Product Name | Cagrilintide |
| Product Category | Amylin Mimetics & Metabolic Peptides |
| Compound Type | Synthetic Long-Acting Amylin/Calcitonin Receptor Agonist |
| Primary Goal | Amylin pathway satiety signaling, delayed gastric emptying, and metabolic synergy research |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. Protect from direct light. |
| Intended Use | Laboratory Research Only |
| Dosage | 10MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
